TriMas (NASDAQ:TRS) Upgraded by Zacks Research to Hold Rating

TriMas (NASDAQ:TRSGet Free Report) was upgraded by equities research analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research note issued to investors on Tuesday,Zacks.com reports.

A number of other equities research analysts have also weighed in on the stock. BWS Financial reaffirmed a “buy” rating and set a $45.00 price target on shares of TriMas in a report on Monday, March 2nd. Weiss Ratings lowered shares of TriMas from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, April 27th. Finally, KeyCorp restated an “overweight” rating and set a $38.00 target price on shares of TriMas in a research note on Thursday, February 26th. Two investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $41.50.

Check Out Our Latest Report on TRS

TriMas Stock Performance

TriMas stock opened at $41.61 on Tuesday. The firm has a market capitalization of $1.49 billion, a PE ratio of 1.73 and a beta of 0.58. TriMas has a one year low of $23.65 and a one year high of $42.48. The stock’s 50 day moving average price is $37.02 and its 200 day moving average price is $35.61. The company has a debt-to-equity ratio of 0.27, a quick ratio of 4.50 and a current ratio of 4.85.

TriMas (NASDAQ:TRSGet Free Report) last issued its quarterly earnings data on Thursday, April 30th. The industrial products company reported $0.24 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.48 by ($0.24). The firm had revenue of $168.28 million during the quarter, compared to analyst estimates of $158.24 million. TriMas had a net margin of 93.79% and a return on equity of 8.38%. During the same period last year, the business earned $0.46 EPS. The firm’s revenue was up 10.3% compared to the same quarter last year. TriMas has set its FY 2026 guidance at 1.500-1.70 EPS. As a group, sell-side analysts expect that TriMas will post 1.63 EPS for the current fiscal year.

Institutional Trading of TriMas

Several institutional investors have recently added to or reduced their stakes in TRS. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in TriMas by 4.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 24,120 shares of the industrial products company’s stock worth $565,000 after acquiring an additional 1,014 shares in the last quarter. Jane Street Group LLC acquired a new stake in shares of TriMas in the 1st quarter valued at about $868,000. Jump Financial LLC lifted its position in shares of TriMas by 80.3% during the second quarter. Jump Financial LLC now owns 72,240 shares of the industrial products company’s stock worth $2,067,000 after purchasing an additional 32,172 shares during the last quarter. Sei Investments Co. grew its stake in TriMas by 16.7% in the second quarter. Sei Investments Co. now owns 101,420 shares of the industrial products company’s stock worth $2,902,000 after purchasing an additional 14,512 shares in the last quarter. Finally, Squarepoint Ops LLC grew its stake in TriMas by 83.3% in the second quarter. Squarepoint Ops LLC now owns 162,775 shares of the industrial products company’s stock worth $4,657,000 after purchasing an additional 73,960 shares in the last quarter. 99.42% of the stock is owned by institutional investors and hedge funds.

TriMas Company Profile

(Get Free Report)

TriMas Corporation is a diversified industrial company headquartered in Bloomfield Hills, Michigan. Established in 1980, TriMas has built a global reputation for designing and manufacturing specialized products that serve a wide array of end markets. The company operates through multiple segments, each focused on high-demand niches where engineered solutions and rigorous quality standards are essential.

The Packaging segment supplies closures, dispensing systems and related components for the personal care, household chemicals, food and beverage, and pharmaceutical markets.

Further Reading

Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.